Alerts will be sent to your verified email
Verify Email
MERCURYLAB
|
Mercury Laboratories
|
Makers Laboratories
|
Concord Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.51 % | 3.8 % | 2.78 % |
|
5yr average Equity Multiplier
|
1.49 | 2.36 | 1.87 |
|
5yr Average Asset Turnover Ratio
|
1.05 | 0.7 | 0.84 |
|
5yr Avg Net Profit Margin
|
6.6 % | -0.21 % | 1.59 % |
|
Price to Book
|
1.58 | 1.23 | 2.76 |
|
P/E
|
18.62 | 71.79 | 167.04 |
|
5yr Avg Cash Conversion Cycle
|
-4.69 Days | 75.08 Days | 233.27 Days |
|
Inventory Days
|
32.68 Days | 107.1 Days | 152.22 Days |
|
Days Receivable
|
115.65 Days | 71.83 Days | 106.22 Days |
|
Days Payable
|
157.73 Days | 106.28 Days | 74.71 Days |
|
5yr Average Interest Coverage Ratio
|
15.15 | 4.73 | 1.69 |
|
5yr Avg ROCE
|
13.49 % | 6.35 % | 8.41 % |
|
5yr Avg Operating Profit Margin
|
11.74 % | 7.59 % | 9.1 % |
|
5 yr average Debt to Equity
|
0.13 | 0.21 | 0.55 |
|
5yr CAGR Net Profit
|
-10.08 % | n/a | -26.55 % |
|
5yr Average Return on Assets
|
7.02 % | 0.25 % | 1.46 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.66 % | 61.27 % | 54.39 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 5.39 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Mercury Laboratories
|
Makers Laboratories
|
Concord Drugs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|